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Abstract Cervical ripening is a crucial process leading to
delivery. Early dilation of the pregnant cervix can contribute
to premature labour. The maturity of the cervix can be
characterized by its resistance to mechanical stretching.
Although a number of compounds are considered to in-
crease cervical resistance (e.g., progesterone, nitric oxide
synthase inhibitors and nonsteroidal anti-inflammatory
drugs), none of them seem to be safe for clinical application.
Other compounds, such as β2-adrenergic receptor (β2-AR)
agonists, have been used for several decades to stop pre-
mature myometrium contractions, but their cervical action
has never been investigated. The aim of this study was to
detect the effects of the β2-AR agonist terbutaline on non-
pregnant and late-pregnant (day 18, 20, 21 or 22) cervices
isolated from Sprague–Dawley rats. Cervical resistance was
measured by means of a mechanical stretching test in vitro,
the β2-AR density was determined by Western blot anal-
ysis, the β2-AR mRNAwas determined by RT-PCR, while
the G-protein activation following cervical β2-AR stimu-
lation with terbutaline was evaluated via a [35S]GTPγS
binding assay.
Terbutaline at 10−6 M increased the cervical resistance of
the late-pregnant samples in vitro from day18 to day 22, but
did not alter the resistance of the nonpregnant samples. This
cervical resistance-increasing effect was concentration de-
pendent and antagonized with propranolol on day 21.
Terbutaline was ineffective on cervical samples when grad-
ual stretching was omitted. RT-PCR and Western blot stud-
ies revealed increased β2-AR mRNA and β2-AR levels
respectively on day 18 of pregnancy compared with the
nonpregnant cervix, but no further changes were detected
up to the end of pregnancy. The [35S]GTPγS binding assay
demonstrated a decreased G-protein activation on the days
of pregnancy investigated, but no activation was found in
the nonpregnant samples. The degree of decrease in G-
protein activation by terbutaline was in harmony with its
cervical resistance-increasing action. On day 21, the G-
protein activation-decreasing effect of terbutaline was an-
tagonized with propranolol.
We presume that the cervical resistance-increasing effect
of terbutaline is a consequence of its G-protein activation-
decreasing property via β2-ARs, which finally leads to an
increased muscle resistance against mechanical stretching.
This action of terbutaline seems unique among the smooth
muscles, and may open up a new perspective in the pre-
vention of premature labour. Clinical experience indicates
that β2-AR agonists will not be sufficient to stop the overall
process, but their combination with more potent inhibitors
of uterine contractions may be of clinical benefit.
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Introduction
Cervical ripening is one of the most important initial steps
leading to delivery. This process includes the dilation, soft-
ening and finally effacement of the cervix (Hayashi 1993).
The cervical maturation is controlled by several factors,
e.g., progesterone (Bienkiewicz 1995), oestrogens (Wang
et al. 2001), prostaglandins (Hertelendy and Zakar 2004),
cytokines (Sennstrom et al. 2000), oxytocin (Umscheid
et al. 1998), nitric oxide (Vaisanen-Tommiska et al. 2003)
and connexins (Lenhart et al. 1999). This process is also
crucial in premature labour, when the early uterine con-
tractions are accompanied by softening of the cervical tis-
sue, as a result of the decreased cervical collagen content
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(Uldbjerg et al. 1983). As a consequence, premature babies
have a lower chance of life and a higher risk of complica-
tions such as respiratory distress syndrome (Hulsmann and
van den Anker 1997). In spite of tremendous efforts, the
prevention of premature birth has not yet been resolved.
Clinical practice has some medical tools with which to
elongate the time of delivery, but these possibilities are
quite limited (Sanchez-Ramos and Huddleston 2003). The-
oretically, enhancement of the cervical resistance could be
one aim of tocolytic therapy, besides the inhibition of pre-
mature contractions of the myometrium. Among the drugs
most frequently used for tocolysis (the prevention of pre-
mature labour) are the β2-adrenergic receptor (β2-AR)
agonists or betamimetics (Gyetvai et al. 1999). These com-
pounds can decrease the uterine activity in the third tri-
mester of pregnancy (Souney et al. 1983), but their cervical
action is not well known. Some human data suggest that
the betamimetics have only slight or insignificant action
on cervical ripening (Goeschen et al. 1985; Lewis et al.
1997), while others indicate that the betamimetics inhibit
the cervical contractions elicited by noradrenaline in vitro
(Bryman et al. 1986). However, no studies have been car-
ried out to investigate the effects of betamimetics on the
resistance of the pregnant cervical smooth muscle.
The aim of our study was to investigate the in vitro
effects of terbutaline on cervices isolated from nonpreg-
nant and late-pregnant (days 18–22) rats. Cervical resis-
tance was characterized by the tissue extensibility in
response to mechanical stretching. The amount of β2-ARs
was determined by Western blot analysis, and the β2-AR
mRNA by means of a reverse transcriptase polymerase
chain reaction (RT-PCR). The G-protein activation of the
β2-ARs was investigated via the [
35S] guanosine-5′-O-(3-
thiotriphosphate) ([35S]GTPγS) binding assay.
Materials and methods
All experiments involving animal subjects were carried
out with the approval of the Hungarian Ethical Commit-
tee for Animal Research (registration number: IV/1813-
1/2002).
Mating of the animals
Mature female (180–200 g) andmale (240–260 g) Sprague–
Dawley rats were mated in a special mating cage. A metal
door, which was movable by a small electric engine, sep-
arated the rooms for the male and female animals. A timer
controlled the function of the engine. Since rats are usually
active at night, the separating door was opened before
dawn. Within 4–5 h after the possibility of mating, vaginal
smears were taken from the female rats, and a sperm search
was performed under a microscope at a magnification of
1,200 times. If the search proved positive, or if smear taking
was impossible because of an existing vaginal sperm plug,
the female rats were separated and were regarded as first-
day pregnant animals.
Measurement of the cervical resistance
Cervical tissues were removed from nonpregnant and late-
pregnant (gestational days 18, 20, 21 or 22) rats. The cervix
was defined as the least vascular tissue with two parallel
lumina between the uterine horns and the vagina. The two
cervical rings were separated and mounted with their
longitudinal axis vertically by hooks in an organ bath
containing 10ml de Jongh buffer (in mM: 137 NaCl, 3 KCl,
1 CaCl2, 1 MgCl2, 12 NaHCO3, 4 NaH2PO4, 6 glucose;
pH 7.4). The organ bath was maintained at 37°C and
carbogen (95% O2+5% CO2) was bubbled through it. The
lower sides of the cervices were fixed to the bottom of the
tissue holders in the organ chambers, while the upper parts
were hooked to gauge transducers (SG-02, Experimetria,
Budapest, Hungary). After mounting, the rings were equil-
ibrated for about 1 h before experiments were undertaken,
with a buffer change every 15 min. The initial tension was
set to about 1.00 g.
Cervical resistance was investigated by gradual increas-
ing by the tension in the tissues. The cervices were stretched
in incremental steps and allowed to relax for 5 min. After
every 5 min the next initial tension was set in the fol-
lowing sequence (in g): 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and
12. The tension was increased manually via the control
screw of a gauge transducer. The precise initial tension
and the relaxation of the cervices were followed with an
online computer, using the SPEL Advanced Isosys Data
Acquisition System (Experimetria). The resultant stress–
strain curves had saw-tooth shapes (Fig. 1). In the eval-
uation of the cervical resistance, the initial tension of the
cervix was plotted versus the stretch after 5 min. Straight
lines were fitted by linear regression and the slopes of the
lines were used to express the degree of resistance. A
steeper slope reflected higher resistance. Fig. 2 depicts
representative straight lines derived from resistance stud-
ies on nonpregnant and day 22 pregnant cervices (Fig. 2).
When the effects of terbutaline were investigated, 10−6 M
(10−9–10−4 M with or without 10−7 M propranolol on day
21) of the drug was added to the organ bath and the cer-
vices were incubated for 5 min. The data were analysed
with the Prism 2.01 (GraphPad Software, San Diego, CA,
USA) computer program, and the slopes of the fitted
straight lines were compared. The ANOVANeuman–Keuls
test was used for statistical evaluations.
When the effect of terbutaline was investigated on basal
(2 g precontraction at the beginning of incubation period)
and precontracted (5 g precontraction at the beginning of
incubation period) cervical tension, cumulative concentra-
tion–response curves of terbutaline were constructed in the
concentration range of 3×10−9–3×10−5 M on 21-day preg-
nant cervices.
RT-PCR studies
Tissue isolation Cervical tissues from nonpregnant and
late-pregnant animals were removed and frozen in liq-
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uid nitrogen and then stored at −70°C until total RNA
extraction.
Total RNA preparation Total cellular RNA was isolated
by extraction with acid guanidinium thiocyanate phenol-
chloroform by the procedure of Chomczynski and Sacchi
(1987). After precipitation with isopropanol, the RNAwas
washed three times with ice-cold 75% ethanol and then
dried. The pellet was resuspended in 100 μl DNase and
RNase-free distilled water. The RNA concentrations of the
samples were determined from their absorbance at 260 nm.
RT-PCR The RNA (0.5 μg) was denatured at 70°C for 5
min in a reaction mixture containing 20 μM oligo(dT) (In-
vitrogen, Paisley, UK), 20 U RNase inhibitor (Invitrogen)
and 200 μM dNTP (Sigma-Aldrich, Budapest, Hungary)
in First Strand Buffer (Invitrogen), in a final reaction vol-
ume of 20 μl. After the mixture had been cooled to 4°C,
20 U M-MLV reverse transcriptase (Gibco, Paisley, UK)
and RNase H Minus (Invitrogen) were added, and the mix-
ture was incubated at 37°C for 60 min.
The PCR was carried out with 5 μl cDNA, 25 μl Ready-
Mix REDTaq PCR reaction mix (Sigma-Aldrich), 2 μl 50
pM sense and antisense primer of the β2-AR subtype and
16 μl DNase and RNase-free distilled water. For the rat
β2-AR cDNA, a 343-bp PCR product resulted with the
forward primer 5′-TCT TCG AAA ACC TAT GGG AAC
GGC-3′ and the reverse primer 5′-GGA TGT GCC CCT
TCT GCA AAA TCT-3′ (Engstrom et al. 2001). A rat
GAPDH probe was used as internal control in all samples
(Tso et al. 1985). The PCR was performed with a PCR
Sprint thermal cycler (Hybaid, Ashford, UK) with the
following cycle parameters: after initial denaturation at
95°C for 2 min, the reactions were taken through 27 cy-
cles of 45 s at 95°C, 45 s at 54°C and 1 min at 72°C,
followed by lowering of the temperature to 4°C. The RT-
PCR products were separated on 2% agarose gels, stained
with ethidium bromide and photographed under a UV
Fig. 1 Representative stress–strain curve of a 22-day pregnant rat
cervix in vitro. The cervices were stretched in incremental steps and
allowed to relax for 5 min. After every 5 min, the next initial tension
value was adjusted. The series of stretching and relaxation resulted
in a saw-tooth shape. The initial tensions were plotted against the
tensions recorded after 5 min to create regression lines (see Fig. 2).
Fig. 2 Representative regression lines fitted to nonpregnant and 22-
day pregnant rat stress–strain curves in vitro. Intermittent and
continuous lines are the regression lines from the nonpregnant and
the 22-day pregnant cervix respectively. The slopes of the straight
lines denote the cervical resistance. A steeper slope means a higher
resistance. The lower resistance of the 22-day pregnant cervix is a
consequence of the ripening process leading to delivery.
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transilluminator. Semiquantitative analysis was performed
by densitometric scanning of the gel with Kodak EDAS290
(Csertex, Budapest, Hungary). For statistical evaluations,
data were analysed by ANOVA with the Neuman–Keuls
test.
Western blot analysis
Ten micrograms of protein per well was subjected to
electrophoresis on 10% sodium dodecylsulfate polyacryla-
mide gels in Series Standard Dual Cooled Units (BioRad,
Budapest, Hungary). Proteins were transferred from gels to
nitrocellulose membranes (Scheicher and Schuell, Dassel,
Germany), using a semidry blotting technique (BioRad).
The membranes were blocked with 5% nonfat dry milk in
Tris saline buffer (in mM: 50 Tris, 200 NaCl; pH 7.4)
containing 0.1% Tween, overnight at 4°C. After washing,
the blots were incubated for 1 h, at room temperature, on a
shaker with β2-AR polyclonal antibody (Santa Cruz Bio-
technology, Santa Cruz, CA, USA; sc-570, 1:200) in the
blocking buffer. The blots were washed and incubated with
1:5,000 peroxidase-conjugated goat anti-rabbit IgG (Santa
Cruz Biotechnology; sc-2004). The antibody binding was
detected with an enhanced chemiluminescence detection
system (Amersham, Little Chalfont, UK) and exposed on
Kodak X-Omat film (Sigma-Aldrich).
[35S]GTPγS binding assay
Rat cervix membrane fractions (≈10 μg of protein/sample)
were incubated at 30°C for 60 min in Tris–EGTA buffer
(in mM: 50 Tris–HCl, 1 EGTA, 3 MgCl2, 100 NaCl; pH
7.4) containing 20 MBq/0.05 cm3 [35S]GTPγS (0.05 nM)
and increasing concentrations (10−10–10−6 M) of terbuta-
line in the presence of excess GDP (30 pM) in a final vol-
ume of 1 ml according to Sim et al. (1995), and Traynor
and Nahorski (1995) with slight modifications. On day 21,
the experiment was also carried out in the presence of
propranolol (10−7 M). Nonspecific binding was determined
with 10 μM GTPγS and subtracted. Bound and free [35S]
GTPγS were separated by vacuum filtration through
Whatman GF/B filters with a Millipore manifold. Filters
were washed with 3×5 ml ice-cold buffer, and the radioac-
tivity of the dried filters was determined in a toluene-based
scintillation cocktail in a Wallac 1,409 scintillation counter
(Turku, Finland). The percentage stimulation caused by
terbutaline was plotted against the concentration of the
drug. Dose–response curves were fitted, and the concen-
trations eliciting half of the maximum effect (EC50) and the
maximum effect (Emax) were calculated and statistically
analysed by means of the ANOVA Neuman–Keuls test.
Results
In the isolated organ bath studies, we found a very limited
extensibility of the nonpregnant cervices. In essence, the
initial tension remained unchanged (slope∼1.00) after 5
min. From day 18, the cervical resistance continuously de-
creased towards term, reaching a trough value on days
21 and 22 (Fig. 3, grated bars). Terbutaline had no effect
on the nonpregnant cervices but elicited cervical resis-
tance-increasing action from day 18 to day 22. This effect
was most marked on days 21 and 22 (Fig. 3, black bars).
The cervical resistance-increasing effect of terbutaline was
concentration dependent within a range of 10−9 to 10−5 M
(Fig. 4a, control) on day 21. This concentration–response
curve was shifted to the right in the presence of 10−7 M
propranolol (Fig. 4a, propranolol; Table 1). Terbutaline
had no effect on the basal (Fig. 5a1) and precontracted
(Fig. 5b1) cervical muscle tone on day 21 within a con-
centration range of 3×10−9 to 3×10−5 M, while the spon-
taneous activity of the nontreated cervices decreased after
15 min (Fig. 5a2, b2).
The RT-PCR studies revealed an increase in cervical β2-
AR mRNA level on day 18. No further change was
detected up to the end of pregnancy (Fig. 6).
Fig. 3 Effects of terbutaline on the cervical resistance of nonpregnant
and late-pregnant rat cervices in vitro (n=8). The resistance is
expressed as the slope of the regression lines fitted to the stress–strain
curves (see Figs. 1, 2). The Y axis is segmented into two in order to
present a higher magnification of the changes in slopes. Grated bars
show the slopes from nontreated, and black bars those from ter-
butaline-treated cervices in vitro. One each day, the level of signif-
icance relates to the comparison with the nontreated (control) sample.
ns not significant, *p<0.05, ***p<0.001
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Western blot analysis pointed to an approximate
doubling of the optical density of the β2-ARs on day 18
compared with the nonpregnant samples. No subsequent
change in this elevated optical density was observed up to
the day of delivery (Fig. 7).
Terbutaline did not alter the [35S]GTPγS binding in the
nonpregnant preparations compared with the basal value.
From day 18 to day 22, terbutaline caused not stimulation,
but a decline in [35S]GTPγS binding. The curve on day 22
was shifted to the left compared with the earlier days
(Fig. 8). The degrees of inhibition of [35S]GTPγS binding
were similar on days 18 and 20; higher inhibitions were
detected on days 21 and 22 (Table 2). The curve of day 21
was shifted to the right in the presence of 10−7 M
propranolol (Fig. 4b; Table 2).
Discussion
The cervical resistance plays a determining role in preg-
nancy. During pregnancy, the cervix is normally firm and
closed. At the end of gestation, however, the cervical tissue
becomes softer and dilates as the myometrial contractions
increase. The harmonised cooperation of these two parts of
the uterus results in safe delivery. In some cases, premature
cervical dilation contributes to premature delivery of the
foetus (Bouyer et al. 1986), which can impair the chances of
the neonate for life. Compounds that increase resistance can
be beneficial in the prevention of premature complications,
but the number of such compounds is quite limited. Pro-
gesterone is the main sex hormone responsible for high
cervical resistance; antigestagens accelerate cervical ripen-
ing (Chwalisz and Garfield 1994). However, the use of
progesterone is not widely accepted for the inhibition of
premature labour; little information is available in this
respect (Fuchs and Stakemann 1959; Noblot et al. 1991). It
is very probable that the diversified actions of progesterone
also contribute to its rare use in late pregnancy, although
new efforts have been made to take advantage of its clin-
ical benefit (Brancazio et al. 2003). Drugs acting against
prostaglandins (nonsteroidal anti-inflammatory drugs—
NSAIDs) and nitric oxide (a nitric oxide synthase inhibitor
—NOSI) may also have beneficial effects on the cervical
resistance in early ripening (Garfield et al. 1998; Shi et al.
2000). NSAIDs have been used in pregnancy, but their
adverse effects on the foetus limit their clinical importance
(Loudon et al. 2003). NOSIs exert paradox action on the
pregnant uterus: they can enhance cervical resistance, but
Fig. 4 The effect of propranolol a on the cervical resistance-
increasing and b G-protein-activating action of terbutaline in 21-day
pregnant cervices (number of independent experiments = 6; number
of animals used for each curve = 12). a The effect of terbutaline on
cervical resistance was expressed as slope difference, which was cal-
culated by the subtraction of the average slope (0.7473) of nontreated
samples from the slope of the treated ones. The drug elicited a con-
centration-dependent increase in slope difference (control curve).
This curve was shifted to the right without significant change in its
maximum value in the presence of 10−7 M propranolol (propranolol
curve; see also Table 1), suggesting the β-adrenergic receptor-
mediated character of terbutaline action on cervical resistance. b
Terbutaline decreased the [35S]GTPγS binding of 21-day pregnant
cervix membranes in a concentration-dependent manner (control
curve). Basal refers to the value of [35S]GTPγS binding without
terbutaline. Nonspecific binding (13% of specific binding) was de-
termined by subtracting the binding in the presence of 10 μM
unlabelled GTPγS from the total (nonstimulated) value. Data are
given as percent stimulation/inhibition over the basal (nonstimulated,
taken as 100%) level. Typical specific binding values represent-
ing constitutive G-protein activity (basal level) was 2,809±206
dpm, while nonspecific binding was found to be 358±102. The
terbutaline curve was shifted to the right without significant change
in its maximum value in the presence of 10−7 M propranolol (pro-
pranolol curve; see also Table 2). This suggests that the activated G-
protein-decreasing effect of terbutaline is mediated via β-adrenergic
receptors.
Table 1 EC50 and Emax values of terbutaline cervical resistance-
increasing effect on 21-day pregnant rat in vitro (n=6). EC50
concentration of terbutaline eliciting half of Emax, Emax maximum
slope difference increasing effect of terbutaline (slope difference is
calculated by the subtraction of the average slope [0.7473] of
nontreated samples from the treated ones), SEM standard error of
mean, ns not significant
EC50±SEM (M) Emax±SEM
Terbutaline 4.9×10−8±1.3×10−8 0.14±0.02
Terbutaline +
propranolol 10−7 M
4.8×10−7±1.1×10−7** 0.13±0.03 (ns)
**p<0.01
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they also enhance the myometrial contractions (Maul et al.
2003), diminishing their own potency in tocolysis. On
the basis of these facts, it can be claimed that the drugs
known to increase the cervical resistance have serious
therapeutic disadvantages and/or have not been tested in
human pregnancy.
β2-AR agonists have been used in tocolytic therapy for
several decades (Ingegarsson 1976). In spite of the doubts,
they are still among the drugs of first choice for this aim,
although their advantages over others (calcium channel
blockers, NSAIDs, magnesium and ethanol) are continu-
ously questioned (Berkman et al. 2003). While the uterine
contractility-decreasing effects of β2-AR agonists have
been studied extensively, no reliable information is avail-
able concerning their cervical action. To know more, how-
Fig. 5 Effects of terbutaline on
the smooth muscle tone in a the
basal and b precontracted cer-
vices on the 21st day of preg-
nancy in vitro. a1 In the basal
experiments, the pretension of
the cervices was 2 g at the
beginning of the incubation pe-
riod. This tension was decreased
to about 0.6–0.8 g after 1 h. The
doses of terbutaline were added
in every 5 min. The cumulative
administration of terbutaline did
not alter the cervical tension.
Although the cervical sample
contractile activity was de-
creased after the dose of 10−7 M,
this phenomenon is a natural
weakening in cervical contrac-
tility after 15 min, as was shown
on a2 the nontreated sample. b1
The pretension of precontracted
samples was 5 g and decreased
to about 1.2–1.5 g at the end of
the incubation period. Terbuta-
line was not able to increase the
cervical tone; however, a further
decrease was detected in the first
15 min of the experiment. The
contractile response of cervix
was also diminished after 15
min, as was also proved on b2
the nontreated sample.
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Fig. 6 Change in mRNA level of the β2-adrenergic receptor in
nonpregnant and late-pregnant rat cervices (n=6). a The β2-adren-
ergic receptor (β2-AR) reverse transcriptase-polymerase chain re-
action and GAPDH products from the total cervical RNA of a
nonpregnant animal and a pregnant animal on days 18, 20, 21 and 22
of pregnancy. The 372- and 585-base pair (bp) PCR products are the
mRNA of β2-ARs and GAPDH respectively. Each band contains
RNA from the cervix of one animal. The RT-PCR products were
stained with ethidium bromide and photographed under a UV trans-
illuminator. Semiquantitative analysis was performed by densito-
metric scanning of the gel, and b the result was expressed in the ratio
of the optical densities of β2-AR/GAPDH. The level of significance
relates to the comparison with the previous investigated day.
***p<0.001
Fig. 7 Change in the β2-adren-
ergic receptor (β2-AR) level in
nonpregnant and late-pregnant
rat cervices (n=6). a The β2-AR
and β-actin Western blot pro-
ducts from nonpregnant and 18-,
20-, 21- and 22-day-pregnant rat
cervices. The 67- and 42-kDa
Western blot products are β2-
ARs and β-actin respectively.
Samples were subjected to gel
electrophoresis on 10% poly-
acrylamide gel. The antibody
binding was detected with an
enhanced chemiluminescence
detection system, and b ex-
pressed as optical density
(semiquantitative) data. The
level of significance relates to
the comparison with the pre-
vious investigated day.
***p<0.001
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ever, we first had to investigate the changes in cervical
resistance during pregnancy.
In the isolated organ studies, we found that the rat
cervical resistance declines towards delivery, a finding
in harmony with the results of others (Shi et al. 1999;
Vedernikov et al. 2000). Our stretching method was more
robust (a 1-g increase in the initial tension every 5 min)
than in the previous studies, where the degree of incre-
mental stretching was 0.2 mm/min (Shi et al. 1999).
(Although we have no means of determining the exact
stretching in millimetres corresponding to a 1-g increase in
cervical tension, it seems very probable that a 200-μm
change in cervical diameter generates less than a 1-g in-
crease in tension.) A discrepancy may be observed in the
slopes of the fitted curves characterizing the cervical re-
sistance. In our experience, the slopes were steeper, re-
flecting the different method of stretching. Nevertheless,
our findings in respect of cervical ripening have the same
outcome as that reported earlier, and our method is there-
fore also considered appropriate to investigate the changes
in cervical resistance during pregnancy.
Terbutaline administered in vitro to the organ bath
increased the cervical resistance in the late-pregnant rats,
but was not active on the nonpregnant samples. On days
18 and 20, this resistance-increasing effect was moderate,
but on days 21 and 22 it was pronounced. On these latter
days, the measured increases in slope exceeded 0.1, i.e.,
very high values in our system, the difference in slope
between the nonpregnant and the 22-day pregnant non-
treated cervices, for example, being 0.18. These results
indicate that terbutaline is a very potent agent, eliciting an
acute increase in cervical resistance against mechanical
stretching.
It is known that the smooth muscle content of the cervix
is quite low, and is reduced further by pregnancy-induced
apoptosis (Leppert and Yu 1994). Therefore, the possibil-
ity that this effect of terbutaline is not a β2-ARs-medi-
ated action has been considered too. In order to create a
Fig. 8 Change in [35S]GTPγS binding following terbutaline treat-
ment in nonpregnant and late-pregnant rat cervical membranes (num-
ber of independent experiment = 6; number of animal used for each
curve = 12). The percentage stimulation caused by terbutaline was
plotted against the concentration of the drug. Basal refers to the value
of [35S]GTPγS bindingwithout terbutaline. Nonspecific binding (10–
13%of specific binding) was determined by subtracting the binding in
the presence of 10 μM unlabelled GTPγS from the total (non-
stimulated) value. Data are given as percentage stimulation over the
basal (nonstimulated, taken as 100%) level. Typical specific binding
values representing constitutive G-protein activity (basal level) were
2,809±206 dpm on each day. At the highest terbutaline concentration
(10−6 M) the specific binding values were 2,760±154; 2,598±141;
2,542±151; 2,485±137 and 2,443±129 dpm in nonpregnant, 18-, 20-,
21- and 22-day pregnant cervices respectively. The declining curves
indicate the decreased G-protein activation following the addition of
terbutaline to the cervical membrane preparations.
Table 2 EC50 and Emax values of terbutaline [
35S]GTPγS binding-inhibitory effect on late-pregnant rat cervix membrane preparations (n=6)
Day of pregnancy Terbutaline Terbutaline + propranolol 10−7 M
EC50±SEM (M) Emax±SEM (%) EC50±SEM (M) Emax±SEM (%)
18 1.1×10−8±0.4×10−8 8.8±0.8 – –
20 9.6×10−9±1.8×10−9 (ns) 9.1±1.0 (ns) – –
21 1.3×10−8±0.5×10−8 (ns) 11.8±0.9* 3.3×10−7±0.8×10−7** 10.1±1.9 (ns)
22 7.1×10−10±0.9×10−10*** 13.3±1.1 (ns) – –
The level of significance in the terbutaline column relates to the comparison with the previous investigated day. The level of significance of
Emax values on days 21 and 22 was <0.05 and <0.01, compared with nonpregnant values, respectively. The level of significance in the
terbutaline + propranolol column relates to the comparison with values of 21-day cervices in the terbutaline column
*p<0.05; **p<0.01; ***p<0.001
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concentration–response curve, 21-day pregnant cervical
samples were used, because the difference between the
nontreated and 10−6 M terbutaline-treated resistance was
highest on this day. In organ bath studies we proved that
the cervical resistance-increasing action of terbutaline is
concentration dependent, and this effect can be antag-
onised with the nonselective β-AR blocker propranolol.
We know that 90% of the β-ARs are β2-ARs in the
pregnant rat uterus (Principe et al. 1997); accordingly, we
can conclude that the cervical resistance-increasing prop-
erty of terbutaline is dominantly related to β2-ARs, al-
though we cannot exclude the roles of β1-ARs. However,
terbutaline was inefficient on the basal cervical muscle
tone, when gradual stretching was omitted. The contractile
response of the cervix samples was eliminated after 15 min,
but—as was proved on nontreated cervical samples—it
should rather be considered as a natural consequence of
tissue fatigue to contract than as a result of pharmacological
action. These results suggest that terbutaline increases the
resistance of the pregnant cervix against incremental
stretching, but apparently does not influence the smooth
muscle basal tone.
We next attempted to find an explanation for this action
because this smooth muscle effect of terbutaline was very
unusual. First, we determined the change in β2-AR mRNA
by RT-PCR. The receptor synthesis was found to be
elevated in the late-pregnant rat cervices compared with the
nonpregnant samples, but no differences were detected
among the investigated pregnant tissues. The same held true
for the β2-AR protein density determined by Western blot
analysis. Although these methods were only semiquantita-
tive (we followed the changes in optical density in both
methods), we concluded that the amount ofβ2-ARs is much
higher in the late-pregnant cervix than in the nonpregnant
tissues, but this difference itself cannot fully explain the
inefficiency of terbutaline in the nonpregnant cervix. For
further explanation, we carried out [35S]GTPγS binding
studies.
The [35S]GTPγS binding assay measures the level of
G-protein activation following agonist occupation of the
G-protein-coupled receptor. This method detects the func-
tional consequence of receptor occupancy in one of the
earliest receptor-mediated events. In the assay, the [35S]
GTPγS replaces endogenous guanosine triphosphate (GTP)
and binds to the α subunit of G-protein (Gα). The γ-
thiophosphate bond is resistant to the hydrolysis of Gα by
GTPase. The labelled Gα subunits therefore accumulate and
can be measured by counting the amount of [35S] incor-
porated (Harrison and Traynor 2003). Surprisingly, in our
studies β2-AR occupancy by terbutaline resulted in a mod-
erate decrease in [35S]GTPγS binding compared with the
basal value in the pregnant samples, while no effect was
found in the nonpregnant cervices, indicating the lack of
further G-protein activation. This latter phenomenon is quite
strange, but not unique, because uncoupled β2-ARs were
already reported in 24-month-old rat aorta (Gurdal et al.
1995). It seems very probable that the relaxing action medi-
ated through β2-AR is not necessary in the nonpregnant
myometrium. The coupling of this receptor to G-protein
may therefore be a result of a later process during pregnancy.
On the other hand, only a few studies have investigated
the changes in [35S]GTPγS binding caused by β2-AR
agonists on different preparations, but none of them re-
ported a fall in [35S]GTPγS level (Cerione et al. 1985;
Garnier et al. 1999). This decrease means that β2-AR stim-
ulation reduces the level of activated G-protein in the
pregnant rat cervix. The degrees of inhibition in [35S]
GTPγS binding (Emax values) were in harmony with the
increases in cervical resistance elicited by terbutaline. On
day 21 the terbutaline action was antagonized with pro-
pranolol, which provides further evidence for the β-AR-
mediated drug effect. The shift to the left in the terbutaline
dose–response curve and the decrease in EC50 on day 22
indicates the higher sensitivity of the β-ARs to this special
action of the drug on the day of delivery.
We assume that the effect of terbutaline is connected
with stimulatory G-proteins (Gs), although an interaction
with inhibitory G-protein (Gi) cannot be excluded, because
protein kinase A-regulated Gi-coupled β2-ARs have al-
ready been reported (Zamah et al. 2002). Additionally, the
assessment of Gs activation seems more difficult than Gi
detection in the [35S]GTPγS binding because Gs subunit
can dissociate from the plasma membrane into the cytosol
(Lee et al. 1999). Nevertheless, Gs exists, at least in part, in a
palmitoylated form closely associated with the membrane
providing the possibility of [35S]GTPγS measurements
(Mumby 1997). We presume that the changes in level of
activated Gs and/or Gi mediate an intracellular process that
is not sufficient to alter the smooth muscle basal tone, but
can provide a stronger resistance against stretching forces.
These facts lead us to conclude that terbutaline has a
unique smooth muscle resistance-increasing effect against
mechanical stretching on the isolated pregnant rat cervix,
which can be explained by the decreased level of activated
G-protein. To the best of our knowledge, this is the first
example of a G-protein-inhibiting effect of terbutaline. It
was shown that nonselective β-AR agonist isoprenaline
inhibits the spontaneous porcine cervical contractions in
vitro (Kitazawa et al. 2001), while other data prove the
opposite on isolated human cervix, although terbutaline
behaved as an inhibitor in this experiment (Bryman et al.
1986). These facts, including our results, suggest some
genus-specific reaction of cervical smooth muscle to β2-
AR agonists. Nevertheless, none of the earlier studies
investigated the β2-AR agonist effect against mechanical
stretching. This action of terbutaline may be promising for
enhancing cervical resistance and sustaining pregnancy in
cases of threatened premature labour. In the light of the
clinical experience it seems very probable that β2-AR
agonists will not be sufficient to stop the whole process, but
their combination with more potent inhibitors of uterine
contractions may have clinical benefits. Certain clinical
data support this possibility (e.g., the successful combina-
tion of terbutaline with magnesium sulfate for tocolysis),
though without any relation to cervical ripening (Kosasa et
al. 1994). The cervical resistance-increasing effect of
terbutaline may open up new perspectives for the clinical
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use of β2-AR agonists in obstetrics. Further studies are
needed to determine the actions of other β2-AR agonists
(e.g., fenoterol, ritodrine or hexoprenaline) in order to
compare the cervical resistance-increasing effects of clin-
ically used β2-mimetics.
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